EXAS [NASD]
Exact Sciences Corporation
Index- P/E- EPS (ttm)-4.10 Insider Own0.80% Shs Outstand177.00M Perf Week9.76%
Market Cap8.03B Forward P/E- EPS next Y-2.64 Insider Trans-1.64% Shs Float176.12M Perf Month40.85%
Income-716.40M PEG- EPS next Q-0.93 Inst Own89.30% Short Float / Ratio5.63% / 4.61 Perf Quarter28.78%
Sales2.01B P/S4.01 EPS this Y36.20% Inst Trans-1.76% Short Interest9.92M Perf Half Y-2.44%
Book/sh17.56 P/B2.59 EPS next Y27.10% ROA-11.10% Target Price60.06 Perf Year-40.53%
Cash/sh3.80 P/C12.00 EPS next 5Y- ROE-22.10% 52W Range29.27 - 87.23 Perf YTD-41.48%
Dividend- P/FCF- EPS past 5Y-16.30% ROI-10.90% 52W High-47.92% Beta1.37
Dividend %- Quick Ratio2.20 Sales past 5Y77.80% Gross Margin72.80% 52W Low55.21% ATR2.30
Employees6420 Current Ratio2.50 Sales Q/Q14.60% Oper. Margin-34.70% RSI (14)63.11 Volatility5.68% 5.56%
OptionableYes Debt/Eq0.72 EPS Q/Q13.40% Profit Margin-35.70% Rel Volume0.64 Prev Close45.55
ShortableYes LT Debt/Eq0.72 EarningsNov 03 AMC Payout- Avg Volume2.15M Price45.43
Recom1.70 SMA205.20% SMA5021.56% SMA200-6.02% Volume774,501 Change-0.26%
Oct-19-22Downgrade Craig Hallum Buy → Hold $60 → $35
Aug-25-22Initiated Credit Suisse Outperform $55
Jun-03-22Initiated Piper Sandler Neutral $50
Nov-03-21Downgrade Raymond James Strong Buy → Outperform $160 → $130
Jul-29-21Reiterated Stifel Buy $165 → $145
Jul-29-21Reiterated Oppenheimer Outperform $161 → $155
Jul-29-21Reiterated Canaccord Genuity Buy $185 → $160
Jul-29-21Reiterated BTIG Research Buy $155 → $145
Jun-15-21Initiated Raymond James Strong Buy $160
Jun-03-21Initiated Goldman Buy $160
Show Previous Ratings
Dec-01-22 09:35AM
Nov-28-22 04:06PM
Nov-24-22 09:55AM
08:37AM
Nov-18-22 02:43PM
07:29PM Loading…
Nov-17-22 07:29PM
Nov-09-22 03:55PM
11:11AM
06:44AM
Nov-08-22 09:55AM
Nov-06-22 07:17AM
Nov-04-22 04:20PM
01:33PM
11:23AM
10:47AM
10:00PM Loading…
Nov-03-22 10:00PM
07:35PM
04:05PM
Nov-01-22 10:01AM
06:00AM
Oct-31-22 12:54PM
Oct-29-22 09:30AM
Oct-27-22 10:02AM
Oct-24-22 10:15AM
07:33AM
Oct-19-22 12:02PM
Oct-13-22 05:21AM
Oct-10-22 06:00AM
Oct-07-22 07:20PM
08:00AM
11:43AM Loading…
Oct-03-22 11:43AM
Sep-29-22 05:29AM
02:53AM
Sep-28-22 11:37AM
Sep-27-22 09:00AM
Sep-21-22 05:30PM
09:33AM
Sep-20-22 01:53PM
11:13AM
Sep-19-22 04:26PM
Sep-10-22 04:33AM
Sep-01-22 11:31AM
06:00AM
Aug-30-22 02:48PM
06:41AM
Aug-24-22 12:22PM
08:10AM
Aug-23-22 02:03PM
Aug-20-22 06:08AM
Aug-19-22 03:24PM
Aug-03-22 05:39PM
12:54PM
12:17PM
Aug-02-22 11:30PM
06:15PM
04:30PM
04:05PM
04:05PM
12:49PM
09:11AM
Aug-01-22 06:00AM
Jul-28-22 03:40PM
Jul-25-22 03:11PM
12:11PM
Jul-14-22 11:21AM
10:15AM
Jul-13-22 11:15AM
Jul-12-22 01:39PM
Jul-08-22 03:47PM
06:00AM
Jul-07-22 10:04AM
Jun-30-22 10:20AM
Jun-28-22 11:58AM
Jun-27-22 09:13AM
Jun-21-22 06:00AM
Jun-14-22 10:47AM
Jun-09-22 11:00AM
May-30-22 10:53AM
May-27-22 08:50AM
06:00AM
May-26-22 02:17PM
May-23-22 11:22AM
May-06-22 10:58AM
May-03-22 10:39AM
May-02-22 06:00AM
Apr-28-22 09:00AM
Apr-27-22 10:25AM
09:54AM
09:41AM
12:30AM
Apr-26-22 06:05PM
Apr-22-22 02:15AM
Apr-08-22 06:00AM
Apr-07-22 10:30AM
Mar-31-22 08:54AM
Mar-30-22 06:15PM
Mar-24-22 11:30AM
Mar-15-22 06:15PM
11:34AM
Mar-09-22 06:15PM
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cunningham EverettChief Commercial OfficerOct 12Sale31.3716,872529,27518,654Oct 13 08:57 PM
Cunningham EverettChief Commercial OfficerOct 11Option Exercise0.0035,006035,526Oct 13 08:57 PM
Baranick BrianGen. Mgr., Precision OncologyAug 05Sale47.1298446,3664,596Aug 08 04:02 PM
Baranick BrianGen. Mgr., Precision OncologyAug 04Option Exercise0.002,71205,580Aug 08 04:02 PM
Zanotti Katherine SDirectorJul 26Option Exercise10.184,60846,90964,926Jul 28 04:04 PM
Zanotti Katherine SDirectorJul 26Sale45.144,608208,00560,318Jul 28 04:04 PM
Conroy Kevin TPresident and CEOJul 01Sale40.7572851,167,927Jul 06 04:11 PM
Zanotti Katherine SDirectorJun 30Sale40.131,08643,58160,318Jul 01 06:20 PM
Doyle James EdwardDirectorJun 07Option Exercise16.523,00049,56042,830Jun 08 04:02 PM
Doyle James EdwardDirectorMar 17Option Exercise16.5210,000165,20039,830Mar 18 04:24 PM
Conroy Kevin TPresident and CEOMar 17Option Exercise6.38236,6221,509,5691,167,606Mar 18 04:22 PM
Condella SarahEVP, Human ResourcesMar 01Sale76.692,816215,95985,762Mar 02 05:31 PM
Conroy Kevin TPresident and CEOMar 01Sale76.6914,2991,096,590930,984Mar 02 05:28 PM
COWARD D SCOTTChief Legal OfficerMar 01Sale76.693,912300,01116,234Mar 02 05:25 PM
Elliott Jeffrey ThomasChief Financial OfficerMar 01Sale76.694,050310,59419,128Mar 02 05:22 PM
Condella SarahEVP, Human ResourcesFeb 28Option Exercise0.005,881088,578Mar 02 05:31 PM
Conroy Kevin TPresident and CEOFeb 28Option Exercise0.0029,8870945,283Mar 02 05:28 PM
COWARD D SCOTTChief Legal OfficerFeb 28Option Exercise0.008,288020,146Mar 02 05:25 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 28Option Exercise0.008,462023,178Mar 02 05:22 PM
Conroy Kevin TPresident and CEOFeb 24Sale70.1027,1261,901,533915,396Feb 25 06:40 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 24Sale70.105,897413,38014,716Feb 25 06:33 PM
Condella SarahSVP, Human ResourcesFeb 24Sale70.104,717330,66288,177Feb 25 06:43 PM
COWARD D SCOTTChief Administrative OfficerFeb 24Sale70.105,815407,63111,858Feb 25 06:37 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 24Sale70.104,717330,66215,037Feb 25 06:31 PM
Conroy Kevin TPresident and CEOFeb 23Option Exercise0.0058,6430942,522Feb 25 06:40 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 23Option Exercise0.0012,747020,613Feb 25 06:33 PM
Condella SarahSVP, Human ResourcesFeb 23Option Exercise0.0010,197092,894Feb 25 06:43 PM
COWARD D SCOTTChief Administrative OfficerFeb 23Option Exercise0.0012,747017,673Feb 25 06:37 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 23Option Exercise0.0010,197019,754Feb 25 06:31 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 23Sale69.051,557107,5117,866Feb 24 07:20 PM
Condella SarahSVP, Human ResourcesFeb 23Sale69.051,12477,61282,697Feb 24 07:16 PM
Conroy Kevin TPresident and CEOFeb 23Sale69.055,188358,231883,879Feb 24 07:14 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 23Sale69.051,12577,6819,557Feb 24 07:10 PM
COWARD D SCOTTChief Administrative OfficerFeb 23Sale69.051,10976,5764,926Feb 24 07:07 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 22Option Exercise0.003,11209,423Feb 24 07:20 PM
Condella SarahSVP, Human ResourcesFeb 22Option Exercise0.002,247083,821Feb 24 07:16 PM
Conroy Kevin TPresident and CEOFeb 22Option Exercise0.0010,3730889,067Feb 24 07:14 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 22Option Exercise0.002,247010,682Feb 24 07:10 PM
COWARD D SCOTTChief Administrative OfficerFeb 22Option Exercise0.002,24706,035Feb 24 07:07 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 22Sale72.721,749127,1878,435Feb 23 05:13 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 18Option Exercise74.133,649270,50010,184Feb 23 05:13 PM
Condella SarahSVP, Human ResourcesFeb 15Sale79.5593874,61881,574Feb 16 08:17 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 15Sale79.551,839146,2926,311Feb 16 08:14 PM
Conroy Kevin TPresident and CEOFeb 15Sale79.5514,4091,146,236878,694Feb 16 08:08 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 15Sale79.5594074,7776,535Feb 16 08:01 PM
COWARD D SCOTTChief Administrative OfficerFeb 15Sale79.551,813144,2243,788Feb 16 07:58 PM
Condella SarahSVP, Human ResourcesFeb 14Option Exercise78.332,030159,01082,512Feb 16 08:17 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 14Option Exercise78.333,972311,1278,150Feb 16 08:14 PM
Conroy Kevin TPresident and CEOFeb 14Option Exercise19.53222,3164,342,004893,103Feb 16 08:08 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 14Option Exercise78.332,030159,0107,475Feb 16 08:01 PM
COWARD D SCOTTChief Administrative OfficerFeb 14Option Exercise78.333,972311,1275,601Feb 16 07:58 PM